Vellinton Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 0.38 M
as on 23-10-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.88 Cr
as on 23-10-2024
- Revenue %
(FY 2023)
- Profit 178.61%
(FY 2023)
- Ebitda -74.52%
(FY 2023)
- Net Worth 179.87%
(FY 2023)
- Total Assets 176.45%
(FY 2023)
About Vellinton Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 0.38 M.
The company currently has active open charges totaling ₹18.88 Cr.
Konic Goyal, Manic Goyal, and Parshotam Goyal serve as directors at the Company.
- CIN/LLPIN
U24231HP2015PTC001015
- Company No.
001015
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vellinton Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Konic Goyal  | Director | 04-Aug-2015 | Current |
| Manic Goyal | Director | 04-Aug-2015 | Current |
| Parshotam Goyal | Director | 04-Aug-2015 | Current |
Financial Performance of Vellinton Healthcare.
Vellinton Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 178.61% increase in profit. The company's net worth Soared by an impressive increase of 179.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vellinton Healthcare?
In 2023, Vellinton Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skincare Fiber Private LimitedActive 4 years 5 monthsKonic Goyal, Manic Goyal and 1 more are mutual person
- Parb Bioceuticals Private LimitedActive 3 years 7 months
Konic Goyal and Parshotam Goyal are mutual person
- Parb Pharmaceuticals Private LimitedActive 2 years 1 month
Konic Goyal and Manic Goyal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Dec 2022 | ₹9.80 Cr | Open |
Others Creation Date: 31 Mar 2022 | ₹5.00 Cr | Open |
Others Creation Date: 31 Mar 2022 | ₹4.61 M | Open |
How Many Employees Work at Vellinton Healthcare?
Unlock and access historical data on people associated with Vellinton Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vellinton Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vellinton Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
